Point72 Asia (Singapore) Pte. Ltd. Ovid Therapeutics Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $646 Billion
- Q3 2025
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 19,173 shares of OVID stock, worth $25,116. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,173
Previous 38,382
50.05%
Holding current value
$25,116
Previous $12.7 Million
96.85%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding OVID
# of Institutions
87Shares Held
33.1MCall Options Held
141KPut Options Held
62.5K-
Black Rock Inc. New York, NY3.99MShares$5.23 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.82MShares$3.7 Million0.0% of portfolio
-
Affinity Asset Advisors, LLC New York, NY2.65MShares$3.47 Million0.39% of portfolio
-
Acadian Asset Management LLC Boston, MA2.29MShares$3 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.02MShares$2.64 Million0.0% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $92.2M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...